We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Imaging Workstation Provides Superior Sensitivity for Gel/Blot Analyses

By LabMedica International staff writers
Posted on 08 Jan 2013
Image: The PXi Multiapplication gel and blot imaging system (Photo courtesy of Syngene).
Image: The PXi Multiapplication gel and blot imaging system (Photo courtesy of Syngene).
A new high resolution, multiapplication imaging system includes a wide range of lighting options, a new-generation camera, and specialized software, enabling exceptional sensitivity for analysis of gels and blots.

The PXi gel and blot imaging system from Syngene (Frederick, MD, USA) is a sophisticated and easy-to-use, compact workstation for the capture and image analysis of chemiluminescent and fluorescent blots, fluorescent and IR gels, visible gels and blots, and even 2D gels. PXi is available in three versions - with a 4, 6, or 8 million pixel high performance camera and suitable lens that results in the system having superior sensitivity such that even faint gels, chemiluminescence blots, and faint fluorescent bands can be imaged. In addition, the cameras are cooled to enable longer exposures, which can be a necessity for chemiluminescence and for some fluorescence applications.

The high performance range of PXi has been designed to provide a high level of control and to excel at a wide range of applications. The system has options for advanced automation or manual control. A number of lighting options can be utilized including plug and play LED modules for Red, Green, Blue and IR light. These novel lighting systems provides the user with the ability to perform colored fluorescent, multiplex, and colorimetric imaging. The new UltraSlim blue LED transilluminator provides a solution for imaging “safe dyes.” An integral 7-position filter wheel can accommodate a wide range of Syngene filters. PXi is controlled by the GeneSys acquisition and capture software. Using its database, GeneSys can automatically configure PXi to capture any type of image.

Related Links:

Syngene



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gold Member
Immunochromatographic Assay
CRYPTO Cassette

Channels

Clinical Chemistry

view channel
Image: The Elecsys pTau-181 test helps rule out Alzheimer’s disease in symptomatic patients aged 55 and older by identifying absence of amyloid pathology (photo courtesy of Roche)

Simple Blood Test Offers New Path to Alzheimer’s Assessment in Primary Care

Timely evaluation of cognitive symptoms in primary care is often limited by restricted access to specialized diagnostics and invasive confirmatory procedures. Clinicians need accessible tools to determine... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more